2002
================================================================================
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITTIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) April 16, 2002
-------------------------------
SPIRE CORPORATION
- --------------------------------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
Massachusetts
- --------------------------------------------------------------------------------
(STATE OR OTHER JURISDICTION OF INCORPORATION)
0-12742 04-2457335
- --------------------------------------------------------------------------------
(COMMISSION FILE NUMBER) (I.R.S. EMPLOYER IDENTIFICATION NO.)
One Patriots Park, Bedford, Massachusetts 01730-2396
- --------------------------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
781-275-6000
- --------------------------------------------------------------------------------
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
================================================================================
ITEM 5. OTHER EVENTS
- ---------------------
Spire Corporation (the "Company") announced on April 16, 2002 that
Spire Biomedical, Inc., its wholly-owned subsidiary, has received 510(k)
clearance from the U.S. Food and Drug Administration to market its patented
Pourchez XpressO(TM) hemodialysis catheter with separated tips. Additional
information is set forth in Exhibit (99) to this Current Report on Form 8-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
- ------------------------------------------
(c) Exhibits
99 News Release of the Company dated April 16, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SPIRE CORPORATION
(Registrant)
Date: April 16, 2002
By: /s/ Roger G. Little
----------------------------------
Roger G. Little
President, Chief Executive Officer
and Chairman of the Board
2
EXHIBIT INDEX
Exhibit Description Page Number
- ------- ----------- -----------
99 News Release of the Company dated April 16, 2002. 4
3